PRIDEVIN M2

bt_bb_section_bottom_section_coverage_image
https://www.larivinpharma.com/wp-content/uploads/2024/04/PRIDEVIN-M2.jpg

Composition

Active Ingredients:

  • Metformin 500 mg (Prolonged Release)
  • Glimepiride 2 mg (SMART Tablets)

Description:
Pridevin M2 combines Metformin and Glimepiride in a SMART tablet formulation to provide effective management of type 2 diabetes mellitus. This prolonged-release combination offers sustained blood glucose control by combining the glucose-lowering action of Metformin with the insulin-secreting stimulation of Glimepiride.

Indications:
Pridevin M2 is indicated for:

  • Management of type 2 diabetes mellitus in adults.
  • Improvement of glycemic control in patients inadequately controlled on Metformin or Glimepiride alone.
  • As an adjunct to diet and exercise to improve blood glucose control.

Mechanism of Action:

  • Metformin: Reduces hepatic glucose production and enhances insulin sensitivity in peripheral tissues, facilitating better glucose uptake and utilization.
  • Glimepiride: A sulfonylurea that stimulates pancreatic insulin release, aiding in the reduction of blood glucose levels.

Dosage and Administration:

  • The usual starting dose is one SMART tablet daily, taken with the morning meal to minimize gastrointestinal side effects.
  • Dosage may be adjusted based on individual patient response and blood glucose levels, with a maximum daily dose of 2,000 mg of Metformin and 4 mg of Glimepiride.

Contraindications:

  • Hypersensitivity to Metformin, Glimepiride, or any component of the SMART tablet.
  • Severe renal impairment or significant liver dysfunction.
  • Type 1 diabetes mellitus or diabetic ketoacidosis.
  • Pregnancy and breastfeeding.

Warnings and Precautions:

  • Regular monitoring of renal function is advised due to the Metformin component.
  • Use with caution in patients with a history of hypoglycemia or those on other antidiabetic treatments.
  • Discontinue use and seek medical attention if symptoms of lactic acidosis (e.g., unusual muscle pain, difficulty breathing) or severe hypoglycemia occur.

Side Effects:
Common side effects may include:

  • Nausea
  • Diarrhea
  • Headache
  • Dizziness

Serious side effects, although rare, may include:

  • Lactic acidosis
  • Severe hypoglycemia
  • Liver dysfunction

Drug Interactions:

  • May interact with other antidiabetic agents, corticosteroids, and diuretics.
  • Caution is advised with medications affecting glucose metabolism or renal function.

Storage:

  • Store in a cool, dry place, away from direct sunlight.
  • Keep out of reach of children.

Packaging:

  • Available in blister packs of 10 SMART tablets.

Disclaimer:
This information is provided for educational purposes only. For personalized medical advice and treatment options, consult a healthcare professional.

https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_04.png
https://www.larivinpharma.com/wp-content/uploads/2024/04/PRIDEVIN-M2.jpg
https://www.larivinpharma.com/wp-content/uploads/2020/04/small_blue_triangle.png
https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_01.png
https://www.larivinpharma.com/wp-content/uploads/2023/03/larivin-pharma-footer-icon-160x160.png
No.32, First Floor, Varadharaja Swamy Nagar, Sri Krishna Nagar, Maduravoyal, Chennai, Tamil Nadu 600095

© 2023 Larivin Pharma Private Limited. All rights reserved